跳至主導覽 跳至搜尋 跳過主要內容

CAR-T cells targeting HLA-G as potent therapeutic strategy for EGFR-mutated and overexpressed oral cancer

  • Yu Chuan Lin
  • , Chun Hung Hua
  • , Hsin Man Lu
  • , Shi Wei Huang
  • , Yeh Chen
  • , Ming Hsui Tsai
  • , Fang Yu Lin
  • , Peter Canoll
  • , Shao Chih Chiu
  • , Wei Hua Huang
  • , Der Yang Cho
  • , Chia Ing Jan*
  • *此作品的通信作者
  • China Medical University Taichung
  • Asia University Taiwan
  • Columbia University
  • Changhua Christian Hospital
  • Central Taiwan University of Science and Technology
  • Veterans General Hospital-Kaohsiung Taiwan

研究成果: 期刊稿件 › 文章 › 同儕審查

13 引文 斯高帕斯(Scopus)

摘要

Oral squamous cell carcinoma (OSCC) is a common malignancy in the world. Recently, scientists have focused on therapeutic strategies to determine the regulation of tumors and design molecules for specific targets. Some studies have demonstrated the clinical significance of human leukocyte antigen G (HLA-G) in malignancy and NLR family pyrin domain-containing 3 (NLRP3) inflammasome in promoting tumorigenesis in OSCC. This is the first study to investigate whether aberrant epidermal growth factor receptor (EGFR) induces HLA-G expression through NLRP3 inflammasome-mediated IL-1β secretion in OSCC. Our results showed that the upregulation of NLRP3 inflammasome leads to abundant HLA-G in the cytoplasm and cell membrane of FaDu cells. In addition, we also generated anti-HLA-G chimeric antigen receptor (CAR)-T cells and provided evidence for their effects in EGFR-mutated and overexpressed oral cancer. Our results may be integrated with OSCC patient data to translate basic research into clinical significance and may lead to novel EGFR-aberrant OSCC treatment.

原文英語
文章編號106089
頁(從 - 到)106089
期刊iScience
卷26
發行號3
DOIs
出版品狀態已出版 - 17 03 2023

文獻附註

© 2023 The Author(s).

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「CAR-T cells targeting HLA-G as potent therapeutic strategy for EGFR-mutated and overexpressed oral cancer」主題。共同形成了獨特的指紋。

引用此